Preliminary Phase IV results for Thyrogen

Genzyme General (GENZ) reported preliminary results from a U.S. Phase IV trial of its Thyrogen thyrotropin injection that showed Thyrogen is useful to diagnose recurrent thyroid cancer in patients who...